Home › Funds › Samsara BioCapital, LLC › MLYS

Samsara BioCapital, LLC position in MLYS

MINERALYS THERAPEUTICS INC · Health Care

Samsara BioCapital, LLC reported holding 5,871,018 shares of MLYS (MINERALYS THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$158.4M, representing 13.01% of its reported portfolio and ranking #3 among its reported holdings. Samsara BioCapital, LLC has disclosed MLYS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)5.87M sh
Reported value held$158.40M
Portfolio Weight13.01%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Samsara BioCapital, LLC's MLYS position evolved

Samsara BioCapital, LLC first disclosed a stake in MLYS in Q3 2023 at 4,519,361 shares (US$43.0M). The position peaked in Q3 2025 at 6,263,151 shares, worth US$237.5M. Across 12 filings, Samsara BioCapital, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 5,871,018 shares valued at US$158.4M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.52M $42.98M New
Q4 2023 4.52M $38.87M Hold
Q1 2024 5.07M $65.52M Add
Q2 2024 5.07M $59.38M Hold
Q3 2024 5.07M $61.46M Hold
Q4 2024 5.07M $62.47M Hold
Q1 2025 5.67M $90.12M Add
Q2 2025 5.67M $76.78M Hold
Q3 2025 6.26M $237.50M Add
Q4 2025 5.87M $213.06M Reduce
Q1 2026 5.87M $159.05M Hold
Q2 2026 5.87M $158.40M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MLYS and 13F data

MLYS (MINERALYS THERAPEUTICS INC) is a Health Care company. 53 other funds we track also report a position in MLYS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$207.6M), Catalys Pacific, LLC (US$196.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$106.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MLYS

All MLYS fund holders →

FAQ

How long has Samsara BioCapital, LLC held MLYS?

Samsara BioCapital, LLC has disclosed MLYS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Samsara BioCapital, LLC's current position in MLYS?

As of Q2 2026, Samsara BioCapital, LLC holds 5.87M shares of MLYS (MINERALYS THERAPEUTICS INC), valued at $158.40M, representing 13.01% of its reported portfolio and ranking #3.

Has Samsara BioCapital, LLC been buying or selling MLYS?

In the latest 13F filing (Q2 2026), Samsara BioCapital, LLC held unchanged its position in MLYS. The position peaked in Q3 2025 at 6.26M shares.

Which other funds hold MLYS?

Other major institutional holders of MLYS include RA CAPITAL MANAGEMENT, L.P., Catalys Pacific, LLC, DEERFIELD MANAGEMENT COMPANY, L.P., among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.